Rentokil Initial PLC (NYSE:RTO) Stock Has Consensus Price Target of $31.90 According to Analysts

Shares of Rentokil Initial PLC (NYSE:RTO – Get Free Report) have received an average rating of “Moderate Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $31.90.

Several analysts have recently commented on RTO shares. The Goldman Sachs Group upgraded Rentokil Initial from a “neutral” rating to a “buy” rating in a report on Monday, July 6th. BNP Paribas Exane cut Rentokil Initial from an “outperform” rating to a “neutral” rating and set a $26.70 price target for the company. in a report on Friday, July 31st. Investec upgraded shares of Rentokil Initial to a “buy” rating in a research report on Wednesday, September 23rd. Zacks Research lowered shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a report on Monday, June 15th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Rentokil Initial in a research report on Monday, August 3rd.

Check Out Our Latest Analysis on RTO

Rentokil Initial Stock Performance

NYSE RTO opened at $19.82 on Friday. The stock’s 50 day simple moving average is $23.43 and its 200 day simple moving average is $28.52. Rentokil Initial has a one year low of $19.50 and a one year high of $34.67.

Rentokil Initial Cuts Dividend

The business also recently declared a dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Friday, August 14th were paid a dividend of $0.2240 per share. This represents a dividend yield of 188.0%. This is a decrease from Rentokil Initial’s previous dividend of $0.4120. The ex-dividend date of this dividend was Friday, August 14th.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Integrated Wealth Concepts LLC acquired a new position in Rentokil Initial during the 2nd quarter worth $57,000. NewEdge Advisors LLC increased its stake in shares of Rentokil Initial by 332.7% in the 2nd quarter. NewEdge Advisors LLC now owns 39,213 shares of the company’s stock valued at $1,122,000 after buying an additional 30,151 shares during the period. Continuum Advisory LLC acquired a new stake in shares of Rentokil Initial in the 2nd quarter valued at $42,000. Versant Capital Management Inc raised its position in shares of Rentokil Initial by 10.8% during the second quarter. Versant Capital Management Inc now owns 9,965 shares of the company’s stock worth $285,000 after acquiring an additional 970 shares during the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Rentokil Initial by 50.5% during the first quarter. Parallel Advisors LLC now owns 2,107 shares of the company’s stock valued at $66,000 after acquiring an additional 707 shares during the period. Institutional investors own 9.91% of the company’s stock.

Rentokil Initial Company Profile

(Get Free Report)

Rentokil Initial plc is a business services company specializing in pest control, hygiene, and related workplace services. Through brands including Rentokil, Terminix, Initial, and Ambius, it provides commercial and residential pest management, washroom hygiene, restroom services, interior landscaping, and other solutions designed to support healthier, safer, and more productive environments.

The company serves customers across a broad range of industries, including healthcare, hospitality, food service, manufacturing, retail, and property management.

Featured Stories

Analyst Recommendations for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.